Investments
82Portfolio Exits
13Funds
7Service Providers
1Expert Collections containing Sante
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Sante in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
10,294 items
Sante Web Traffic
Sante Rank
Latest Sante News
Jul 13, 2022
8h agoPrivate EquityunquoteViews: 10 Five Arrows has sold Hygie31, a France-based pharmacy chain that includes low-cost brand Laf Sante, to Latour Capital in an auction preempted by the French sponsor. Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN
Sante Investments
82 Investments
Sante has made 82 investments. Their latest investment was in Endovascular Engineering as part of their Series A - II on April 4, 2022.
Sante Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/5/2022 | Series A - II | Endovascular Engineering | $15M | Yes | 2 | |
3/24/2022 | Series A - III | Geneos Therapeutics | $17M | No | 9 | |
1/26/2022 | Series A - II | Reimagine Care | $18.75M | Yes | 6 | |
1/11/2022 | Series A | |||||
10/26/2021 | Series A |
Date | 4/5/2022 | 3/24/2022 | 1/26/2022 | 1/11/2022 | 10/26/2021 |
|---|---|---|---|---|---|
Round | Series A - II | Series A - III | Series A - II | Series A | Series A |
Company | Endovascular Engineering | Geneos Therapeutics | Reimagine Care | ||
Amount | $15M | $17M | $18.75M | ||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 2 | 9 | 6 |
Sante Portfolio Exits
13 Portfolio Exits
Sante has 13 portfolio exits. Their latest portfolio exit was Farapulse on June 24, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/24/2021 | Acquired | 16 | |||
9/30/2019 | Reverse Merger | 2 | |||
12/27/2018 | Acquired | 2 | |||
Date | 6/24/2021 | 9/30/2019 | 12/27/2018 | ||
|---|---|---|---|---|---|
Exit | Acquired | Reverse Merger | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 16 | 2 | 2 |
Sante Fund History
7 Fund Histories
Sante has 7 funds, including Sante Health Ventures IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/16/2021 | Sante Health Ventures IV | $260M | 4 | ||
5/29/2019 | Sante Health Ventures III | ||||
4/5/2019 | Gateway VCA 0319 | ||||
4/11/2014 | Sante Health Ventures II | ||||
4/17/2008 | Sante Health Ventures |
Closing Date | 9/16/2021 | 5/29/2019 | 4/5/2019 | 4/11/2014 | 4/17/2008 |
|---|---|---|---|---|---|
Fund | Sante Health Ventures IV | Sante Health Ventures III | Gateway VCA 0319 | Sante Health Ventures II | Sante Health Ventures |
Fund Type | |||||
Status | |||||
Amount | $260M | ||||
Sources | 4 |
Sante Team
9 Team Members
Sante has 9 team members, including current Chief Operating Officer, Steven E Seach.
Name | Work History | Title | Status |
|---|---|---|---|
Steven E Seach | Chief Operating Officer | Current | |
Joe Cunningham | Managing Director | Current | |
Joe Cunningham | Managing Director | Current | |
James Eadie | U.S. Air Force | Managing Director | Current |
Douglas D. French | Managing Director | Current |
Name | Steven E Seach | Joe Cunningham | Joe Cunningham | James Eadie | Douglas D. French |
|---|---|---|---|---|---|
Work History | U.S. Air Force | ||||
Title | Chief Operating Officer | Managing Director | Managing Director | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.